{"id":"W3087964189","doi":"10.1016/j.annonc.2020.08.1544","title":"1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Placebo; Discontinuation; Quality of life (healthcare); Nausea; Clinical trial; Clinical endpoint; Pembrolizumab; Internal medicine; Cancer; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001431983,0.0002420576,0.001654495,0.0002037048,0.00007620099,0.000005497493,0.0001877563,0.0002165992,0.0001814634],"category_scores_gemma":[0.005644383,0.000191019,0.0001415565,0.0004777032,0.0002384876,0.00006477005,0.0001565387,0.0003376032,0.000008332549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001215355,"about_ca_system_score_gemma":0.001502705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0020934,"about_ca_topic_score_gemma":0.001935427,"domain_scores_codex":[0.9969113,0.0003786906,0.001278287,0.0004765978,0.0003782552,0.0005768518],"domain_scores_gemma":[0.9962684,0.002047003,0.0004709146,0.0002889056,0.0004261376,0.0004986568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5956374,0.003077567,0.0353421,0.00704902,0.002609754,0.0001638783,0.04159915,0.000479442,0.01294796,0.001881612,0.1635038,0.1357083],"study_design_scores_gemma":[0.1827233,0.2349668,0.3140934,0.001539435,0.0001539919,0.00008715867,0.004387699,0.001762159,0.03522507,0.003083312,0.2206282,0.001349422],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8065711,0.003320354,0.0000522034,0.1863721,0.00007370506,0.00248186,0.0001124654,0.00003641317,0.0009798023],"genre_scores_gemma":[0.9799604,0.003894821,0.00073168,0.01469564,0.0001309378,0.0002479315,0.0000299,0.00003555301,0.0002731433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4129142,"threshold_uncertainty_score":0.7789528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2840961509382641,"score_gpt":0.5052354451313433,"score_spread":0.2211392941930793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}